-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
This article is from the NEJM Journal Watch
Hyperbaric Oxygen Might Improve Symptoms in Patients with “Long COVID”
Hyperbaric oxygen has the potential to improve symptoms in patients with long-term sequelae of COVID-19
Review by Anthony L.
In one randomized trial, 8-week hyperbaric oxygen therapy was associated
Due to the small size of the study and the lack of good controls, the history of hyperbaric oxygen as a treatment for various diseases is tortuous
The researchers used hyperbaric oxygen therapy or sham therapy for 73 patients with long-term sequelae of COVID-19 for 5 days a week for a total of 8 weeks
comments
This thought-provoking paper establishes good controls and demonstrates that there is an objective improvement in the brain and that there is an improvement
Articles that are commented on
Zilberman-Itskovich S et al.
NEJM journals
The NEJM Journal Watch is published by neJM Group, and internationally renowned doctors are invited to review important papers in the field of medicine to help doctors understand and apply the latest developments